Spontaneously proliferating human B lymphocytes make autoantibodies. 1988

G P Allaway, and J Srinivasappa, and F W Miller, and B S Prabhakar, and A L Notkins
Laboratory of Oral Medicine, National Institute of Dental Research, Bethesda, Maryland 20892.

Peripheral blood lymphocytes from 29 patients with autoimmune diseases and eight normal controls were cultured in vitro. Several weeks later, lymphocyte proliferation was observed in many of these cultures. Cell lines were obtained from about half of the donors, at a frequency of approximately 1 in 10(7) lymphocytes. Outgrowth occurred only in cultures from patients who had antibodies to the viral capsid antigen of Epstein-Barr virus (EBV). The proliferating cells also contained EBV nuclear antigen, an occurrence confirming that proliferation was a result of latent EBV infection of the donors. Supernatants from these cell lines were tested for autoantibodies by screening against normal tissues. About 30% of the cell lines made autoantibodies, many of which reacted with smooth muscle or epithelial cells. Because EBV is harbored in a latent form in the majority of the adult population, reactivation of latent EBV infection in vivo may explain the production of autoantibodies seen in a variety of immunoregulatory disorders.

UI MeSH Term Description Entries
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009687 Nuclear Proteins Proteins found in the nucleus of a cell. Do not confuse with NUCLEOPROTEINS which are proteins conjugated with nucleic acids, that are not necessarily present in the nucleus. Nucleolar Protein,Nucleolar Proteins,Nuclear Protein,Protein, Nuclear,Protein, Nucleolar,Proteins, Nuclear,Proteins, Nucleolar
D002213 Capsid The outer protein protective shell of a virus, which protects the viral nucleic acid. Capsids are composed of repeating units (capsomers or capsomeres) of CAPSID PROTEINS which when assembled together form either an icosahedral or helical shape. Procapsid,Prohead,Capsids,Procapsids,Proheads
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004854 Herpesvirus 4, Human The type species of LYMPHOCRYPTOVIRUS, subfamily GAMMAHERPESVIRINAE, infecting B-cells in humans. It is thought to be the causative agent of INFECTIOUS MONONUCLEOSIS and is strongly associated with oral hairy leukoplakia (LEUKOPLAKIA, HAIRY;), BURKITT LYMPHOMA; and other malignancies. Burkitt Herpesvirus,Burkitt Lymphoma Virus,E-B Virus,EBV,Epstein-Barr Virus,Human Herpesvirus 4,Infectious Mononucleosis Virus,Burkitt's Lymphoma Virus,HHV-4,Herpesvirus 4 (gamma), Human,Burkitts Lymphoma Virus,E B Virus,E-B Viruses,Epstein Barr Virus,Herpesvirus, Burkitt,Infectious Mononucleosis Viruses,Lymphoma Virus, Burkitt,Mononucleosis Virus, Infectious,Mononucleosis Viruses, Infectious
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

G P Allaway, and J Srinivasappa, and F W Miller, and B S Prabhakar, and A L Notkins
February 2000, The Journal of nutrition,
G P Allaway, and J Srinivasappa, and F W Miller, and B S Prabhakar, and A L Notkins
January 1997, Human antibodies,
G P Allaway, and J Srinivasappa, and F W Miller, and B S Prabhakar, and A L Notkins
October 1990, The Journal of experimental medicine,
G P Allaway, and J Srinivasappa, and F W Miller, and B S Prabhakar, and A L Notkins
January 1995, Scandinavian journal of immunology,
G P Allaway, and J Srinivasappa, and F W Miller, and B S Prabhakar, and A L Notkins
June 1983, Journal of immunology (Baltimore, Md. : 1950),
G P Allaway, and J Srinivasappa, and F W Miller, and B S Prabhakar, and A L Notkins
July 2017, Diabetologia,
G P Allaway, and J Srinivasappa, and F W Miller, and B S Prabhakar, and A L Notkins
January 1993, Sheng li ke xue jin zhan [Progress in physiology],
G P Allaway, and J Srinivasappa, and F W Miller, and B S Prabhakar, and A L Notkins
April 1985, Journal of immunological methods,
G P Allaway, and J Srinivasappa, and F W Miller, and B S Prabhakar, and A L Notkins
August 1992, Mutation research,
G P Allaway, and J Srinivasappa, and F W Miller, and B S Prabhakar, and A L Notkins
March 1979, Transplantation proceedings,
Copied contents to your clipboard!